World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2699)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

147

HTML

1311

Figures (1-2)

293

Tables (1-1)

274

Sum=2025

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

476

Sum=555

May 27, 2025 (publication date) through Mar 5, 2026

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Shetty S, Suvarna R, Ambrose Fistus V, Modi S, Pappachan JM. Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis. World J Hepatol 2025; 17(5): 105706 [PMID: 40501478 DOI: 10.4254/wjh.v17.i5.105706]
URL:	https://www.wjgnet.com/1948-5182/full/v17/i5/105706.htm

Number	Citing Articles
1	Matheus Henrique Gonçalves de Souza, Pedro Miguel Mattos Nogueira, Cristiane Alves Villela-Nogueira. Metabolic dysfunction-associated steatotic liver disease and diabetes: Together against the heart. World Journal of Hepatology 2025; 17(9): 109737 doi: 10.4254/wjh.v17.i9.109737 Abstract(57) \| Core Tip(49) \| Full Article(HTML)(176) \| Full Article with Cover (PDF)-728K(59) \| Audio-616K(8) \| Peer-Review Report-253K(20) \| Answering Reviewers-123K(35) \| Full Article (PDF)-397K(64) \| Full Article (XML)-78K(21) \| Times Cited (0) \| Total Visits (1887) \| Open
2	Abul Bashar Mohammad Kamrul-Hasan, Sanja Borozan, Sweekruti Jena, Lakshmi Nagendra, Deep Dutta, Saptarshi Bhattacharya, Md Saiful Islam, Joseph M Pappachan. Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: A systematic review. World Journal of Gastrointestinal Pharmacology and Therapeutics 2025; 16(3): 110709 doi: 10.4292/wjgpt.v16.i3.110709 Abstract(90) \| Core Tip(94) \| Full Article(HTML)(676) \| Full Article with Cover (PDF)-819K(53) \| Audio-625K(8) \| Peer-Review Report-261K(32) \| Answering Reviewers-204K(33) \| Supplementary Material-571K(39) \| Full Article (PDF)-567K(112) \| Full Article (XML)-161K(31) \| Times Cited (1) \| Total Visits (3781) \| Open
3	Peter Chinedu Agu, Appolonia Fulgence Yudas, Jun Lu. Dual-Target Insight into Drug Discovery from Natural Products as Modulators of GLP-1 and the TXNIP–Thioredoxin Antioxidant System in Metabolic Syndrome. Antioxidants 2025; 14(11): 1364 doi: 10.3390/antiox14111364
4	Amedeo Lonardo, Ralf Weiskirchen. PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100590